RT Journal Article
T1 Impact of Detection Mode in a Large Cohort of Women Taking Part in a Breast Screening Program.
A1 García, Marilina
A1 Redondo, Maximino
A1 Zarcos, Irene
A1 Louro, Javier
A1 Rivas-Ruiz, Francisco
A1 Téllez, Teresa
A1 Pérez, Diego
A1 Medina Cano, Francisco
A1 Machan, Kenza
A1 Domingo, Laia
A1 Del Mar Vernet, Maria
A1 Padilla-Ruiz, Maria
A1 Castells, Xavier
A1 Sala, Maria
K1 Breast cancer
K1 risk factors
K1 screening
K1 survival
AB The aim of this study was to evaluate the existing survival rate and clinical-pathological differences among patients with breast cancer detected by mammographic screening. This multicenter cohort study examined 1,248 patients who took part in a national screening program for the early detection of breast cancer over an eight-year period. Of the two patient subgroups (interval and screening), we found significant differences in the distribution of prognostic factors, with interval cases presenting at a lower mean age (p = 0.002), with higher percentages of human epidermal growth factor receptor 2 (HER-2) or triple negative and lower percentages of luminal A or luminal B carcinomas (p = 0.001), advanced stages (p Our results highlight that breast tumors detected during the first screening round are frequently characterized by a more benign phenotype than the rest of the screening subgroups, which could be of help when stratifying the risk of death and selecting the best treatment option for each patient.
SN 2587-0831
YR 2022
FD 2022-04-01
LK http://hdl.handle.net/10668/21636
UL http://hdl.handle.net/10668/21636
LA en
DS RISalud
RD Apr 12, 2025